Successful treatment of recurrent lupus enteritis with rituximab

Abstract

Get full access to this article

View all access options for this article.

References

Sultan SM , Ioannou Y. , Isenberg DA A review of gastrointestinal manifestations of systemic lupus erythematosus . Rheumatology (Oxford) 1999; 38: 917-932.

Sanchez-Guerrero J. , Reyes E. , Alarcon-Segovia D. Primary antiphospholipid syndrome as a cause of intestinal infarction. J Rheumatol 1992; 19: 623-625.

Kim YG , Ha HK , Nah SS , Lee CK , Moon HB , Yoo B. Acute abdominal pain in systemic lupus erythematosus: factors contributing to recurrence of lupus enteritis. Ann Rheum Dis 2006; 65: 1537-1538. (letter).

Waite L. , Morrison E. Severe gastrointestinal involvement in systemic lupus erythematosus treated with rituximab and cyclophosphamide (B-cell depletion therapy). Lupus 2007; 16: 841-842.

Garcia-Carrasco M. , Jimenez-Hernandez M. , Escarcega RO , Mendoza-Pinto C. , Galarza-Maldonado C. , Sandoval-Cruz M. , et al. Use of rituximab in patients with systemic lupus erythematosus: an update. Autoimmun Rev 2009; 8: 343-348.

Ng KP , Cambridge G. , Leandro MJ , Edwards JC , Ehrenstein M. , Isenberg DA B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of response. Ann Rheum Dis 2007; 66: 1259-1262.